You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (29)

Journals (0)

1-10 of 29 results for gemcitabine plus nab-paclitaxel

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: S-1 plus oxaliplatin versus modified FOLFIRINOX for advanced pancreatic adenocarcinoma after gemcitabine plus nab-paclitaxel failure

Open access

Research article

First published 2025

S-1 plus oxaliplatin versus modified FOLFIRINOX for advanced pancreatic adenocarcinoma after gemcitabine plus nab-paclitaxel failure

Hui Tang, Zhengxia Li, Tingting You [...]

Therapeutic Advances in Medical Oncology

Select article: Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study

Open access

Research article

First published 2026

Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study

Kuan-Yu Tseng, Chiann-Yi Hsu, Cheng-Han Wu [...]

Therapeutic Advances in Medical Oncology

Select article: A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study

Open access

Research article

First published 2022-11

A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study

Chen Chang, Lingwei Meng, Xiaofen Li [...]

Cancer Control

Select article: Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Open access

Research article

First published 2021

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang [...]

Therapeutic Advances in Medical Oncology

Select article: French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as second-line treatment in metastatic pancreatic cancer patients

Open access

Research article

First published 2024

French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as second-line treatment in metastatic pancreatic cancer patients

Amaury Demaziere, Charline Mourgues, Céline Lambert [...]

Therapeutic Advances in Medical Oncology

Select article: nab -Paclitaxel Plus Gemcitabine Regimen for Pancreatic Cancer

Retricted access

Research article

First published 2014-1

nab -Paclitaxel Plus Gemcitabine Regimen for Pancreatic Cancer

Courtney E. Porter, J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Select article: Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

Open access

Research article

First published 2020

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

Heejung Chae, Hyehyun Jeong, Jaekyung Cheon [...]

Therapeutic Advances in Medical Oncology

Select article: Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter,single-arm,open-label,phase 2 trial

Open access

Research article

First published 2021

Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter,single-arm,open-label,phase 2 trial

Gunn Huh, Hee Seung Lee, Jin Ho Choi [...]

Therapeutic Advances in Medical Oncology

Select article: Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

Open access

Review article

First published 2019

Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

Elena Gabriela Chiorean, Winson Y. Cheung, Guido Giordano [...]

Therapeutic Advances in Medical Oncology

Select article: Corrigendum to Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

Open access

Correction

First published 2019

Corrigendum to Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

Therapeutic Advances in Medical Oncology

1
2
3
10 / page

Article type

Publication date

Subjects

Access